MODERNA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 121.9 USD | +0.68% |
|
+9.36% | +22.56% |
| May. 07 | UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating | MT |
| May. 06 | News Highlights : Top Financial Services News of the Day - Monday at 4 PM ET | DJ |
ETFs positioned on Moderna, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 5.66% | 0 M€ | 0.00% | - | |
| 4.69% | 2 M€ | -.--% | ||
| 4.08% | 0 M€ | 0.00% | - | |
| 2.50% | 0 M€ | -2.17% | - | |
| 2.40% | 0 M€ | +5.54% | - | |
| 2.08% | 7 M€ | -.--% | - | |
| 1.81% | 0 M€ | -.--% | ||
| 1.36% | 9 M€ | -4.31% | - | |
| 1.21% | 1 M€ | +2.21% | - | |
| 0.90% | 0 M€ | +1.74% | ||
| 0.81% | 0 M€ | 0.00% | - | |
| 0.72% | 0 M€ | +8.89% | ||
| 0.63% | 0 M€ | 0.00% | - | |
| 0.60% | 9 M€ | -.--% | - | |
| 0.55% | 5 M€ | -72.95% | - | |
| 0.45% | 0 M€ | 0.00% | - | |
| 0.34% | 0 M€ | -.--% | ||
| 0.30% | 0 M€ | +12.96% | ||
| 0.22% | 0 M€ | +17.51% | - | |
| 0.21% | 0 M€ | +4.60% | - | |
| 0.21% | 0 M€ | +0.78% | - | |
| 0.21% | 0 M€ | +4.60% | - |
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows:
- revenue from product sales (95.7%) ;
- revenues from grants (4%);
- revenues from collaboration agreements (0.3%).
At the end of 2021, the group possessed a portfolio of 15 products in clinical development, of which 3 in phase III, 8 in phase II and 4 in phase I, and 12 products in preclinical development.
Net sales are distributed geographically as follows: the United States (33.4%), Europe (37.1%) and other (29.5%).
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
121.9
USD
Average target price
138.7
USD
Spread / Average Target
+13.77%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.56% | 46.71B | |
| -1.51% | 41.52B | |
| +48.83% | 41.8B | |
| -3.42% | 29.55B | |
| +10.13% | 25.78B | |
| -20.44% | 19.26B | |
| +26.45% | 11.98B | |
| -0.14% | 12.14B | |
| -0.47% | 12.08B | |
| +18.74% | 11.58B |
- Stock Market
- Equities
- MRNA Stock
- Funds and ETFs Moderna, Inc.